Yuhan Corp Preferred (000105) - Total Liabilities
Based on the latest financial reports, Yuhan Corp Preferred (000105) has total liabilities worth ₩836.23 Billion KRW (≈ $566.70 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Yuhan Corp Preferred cash conversion from operations to assess how effectively this company generates cash.
Yuhan Corp Preferred - Total Liabilities Trend (2014–2024)
This chart illustrates how Yuhan Corp Preferred's total liabilities have evolved over time, based on quarterly financial data. Check 000105 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Yuhan Corp Preferred Competitors by Total Liabilities
The table below lists competitors of Yuhan Corp Preferred ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jati Tinggi Group Berhad
KLSE:0292
|
Malaysia | RM71.08 Million |
|
Onward Technologies Limited
NSE:ONWARDTEC
|
India | Rs1.09 Billion |
|
The Intergroup Corporation
NASDAQ:INTG
|
USA | $215.68 Million |
|
DANIEL THWAITES LS-25
F:7KW
|
Germany | €108.20 Million |
|
Ekinops SA
PA:EKI
|
France | €86.49 Million |
|
Dagi Giyim Sanayi ve Ticaret AS
IS:DAGI
|
Turkey | TL2.35 Billion |
|
KB No.2 Special Purpose Acq
KQ:192250
|
Korea | ₩69.18 Billion |
|
UIL Co. Ltd
KQ:049520
|
Korea | ₩86.63 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down Yuhan Corp Preferred's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Yuhan Corp Preferred stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Yuhan Corp Preferred's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Yuhan Corp Preferred (2014–2024)
The table below shows the annual total liabilities of Yuhan Corp Preferred from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩791.38 Billion ≈ $536.31 Million |
+88.70% |
| 2023-12-31 | ₩419.38 Billion ≈ $284.21 Million |
-9.80% |
| 2022-12-31 | ₩464.92 Billion ≈ $315.07 Million |
-11.93% |
| 2021-12-31 | ₩527.92 Billion ≈ $357.77 Million |
-3.49% |
| 2020-12-31 | ₩547.02 Billion ≈ $370.71 Million |
+17.08% |
| 2019-12-31 | ₩467.21 Billion ≈ $316.62 Million |
-10.51% |
| 2018-12-31 | ₩522.08 Billion ≈ $353.80 Million |
+6.91% |
| 2017-12-31 | ₩488.35 Billion ≈ $330.95 Million |
-11.11% |
| 2016-12-31 | ₩549.39 Billion ≈ $372.31 Million |
+6.39% |
| 2015-12-31 | ₩516.39 Billion ≈ $349.95 Million |
+51.83% |
| 2014-12-31 | ₩340.11 Billion ≈ $230.49 Million |
-- |
About Yuhan Corp Preferred
Yuhan Corporation manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally. It also manufactures and sells animal feed and health functional food. The company was founded in 1926 and is headquartered in Seoul, South Korea.